1. Department of Urology, Telemark Hospital Trust, Skien, Norway;
2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway;
3. National Advisory Unit for Late Effects after Cancer Therapy, Oslo University Hospital, Radiumhospitalet, Oslo, Norway;
4. Department of Research and Development, Vestfold Hospital Trust, Tønsberg, Norway;
5. Department of Research and Development, Telemark Hospital Trust, Skien, Norway;
6. Department of Pharmaceutical Bioscience, School of Pharmacy, University of Oslo, Norway;
7. Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway;
8. Institute of Cancer Genomics and Informatics, Oslo University Hospital, Oslo, Norway